Inhaled nitric oxide for cardiac disease

Respiratory Care

Volumn 44, Issue 2, 1999, Pages 196-202

  Rich, George F ^a   Lowson, Stuart M ^a   Baum, Victor C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cardiac disease; Cardiac failure; Cardiac transplant; Nitric oxide; NO; Pulmonary hypertension; Ventricular assist device

Indexed keywords

NITRIC OXIDE;

CONFERENCE PAPER; DRUG MECHANISM; HEART ASSIST DEVICE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; INHALATION ANESTHESIA; MITRAL VALVE REPLACEMENT; OPERATING ROOM; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PULMONARY HYPERTENSION;

EID: 0032937454     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Hines R Post-cardiac surgery pulmonary hypertension (review). J Cardiothoroc Vasc Anesth 1993;7(2 Suppl 1):8-11.
2. Lake CL Perioperative management of increased pulmonary vascular resistance. In: Cardiothoracic and vascular anesthesia update. Philadelphia PA; W B Saunders Co., 1990:1-21.
3. Rich GF, Murphy GD Jr. Roos CM, Johns RA. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993;78(10):1028-1035.
4. Girard C, Lehot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77(5): 880-883.
5. Snow DJ, Gray SJ, Ghosh S, Foubert L, Oduro A, Higenbottam TW, Wells FC, Latimer RD. Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth 1994;72(2):185-189.
6. Lindberg L, Larsson A, Steen S, Olsson SG, Nordstrom L. Nitric oxide gives maximal response after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1994;8(2):182-187.
7. Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: tenth official report-1993. J Heart Lung Transplant 1993;12(4):541-548.
8. Kieler-Jensen N, Ricksten SE, Stenqvist O, Bergh CH, Lindelov B, Wennmalm A, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13(3):366-375.
9. Speziale G, De Biase L, De Vincentis G, Lerardi M, Ruvolo G, La Francessca S, et al. Inhaled nitric oxide in patients with severe heart failure: changes in lung perfusion and ventilation detected using scinugraphy. Thorac Cardiovasc Surg 1996;44(1) 35-39.
10. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995;151(4):1263-1266.
11. Chen EP, Bittner HB, Davis RD Jr. Van Trigt 3rd. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg 1997;63(6):1546-1555.
12. Kieler-Jensen N, Lundin S, Ricksten SE. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin EI. and sodium nitroprusside. J Heart Lung Transplant 1995;14(3) 436-443.
13. Girard C, Durand PG, Vedrinne C, Pannetier JC, Estanove S, Falke K, et al. Case 4-1993 inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vase Anesth 1993;7(4): 481-485.
14. Frazier OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53(6): 1080-1090.
15. Argenziano M, Choudhri A, Moazami N, Rose EA, Smith CR, Levin HR, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 1998;65(2):340-345.
16. Wagner F, Dandel M, Gunther G, Loebe M, Schulze-Neick I, Laucke U, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation 1997;96(9 Suppl):11-291-296.
17. Fierobe L, Brunet F, Dhainaut JF, Monchi M, Belghith M, Mini JP, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151(5):1414-1419.
18. Rossaint R, Slama K, Steudel W, Gerlach H, Pappert D, Veit S, Falke K. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med 1995;21(3):197-203.
19. Benzing A, Mols G, Beyer U, Geiger K, Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide. Acta Anaesthesiol Scand 1997;41(5): 643-647.
20. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90(6):2780-2785.
21. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25(7):1656-1664.
22. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24(4):982-988.
23. Bocchi EA, Bacal F, Auler OC Jr, Carmone MJ, Bellotti G, Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 1994;74(1):70-72.
24. Dickstein ML, Burkhoff D. A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressure; implications for inhaled nitric oxide therapy. J Heart Lung Transplant 1996;15(7): 715-721.
25. Hare JM, Shernon SK, Body SC, Graydon E, Colucci WS, Couper GS. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance Circulation 1997;95(9):2250-2253.
26. Finkel M, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257(5068):387-389.
27. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265(1 Pt 2);H176-182.
28. Hare JM, Loh E, Creager MA, Colucci WS Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92(8):2198-2203.
29. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation 1998;97(2):161-166.
30. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995;27(1) 155-167.
31. Argenziano M, Dean DA, Moazami N, Goldstern DJ, Rose EA, Spotnitz HM, et al. Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorae Cardiovasc Surg 1998;115(3):700-708.
32. Hayward CS, Kalnins WV, Rogers P, Feneley MP, MacDonald PS, Kelly RP Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol 1997;30(1):49-56.
33. Koelling TM, Kirmse M, Di Salvo TG, Dec GW, Zapol WM, Semigran MJ. Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardtol 1998;81(12):1494-1497.
34. Atz AM, Adatia I, Jonas RA, Wessel DL. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Am J Cardiol 1996;77(4):316-319.
35. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88(5 Pt 1):2128-2138.
36. Gamillscheg A, Zobel G, Urlesberger B, Berger J, Dacar D, Stein JI, Rigler B, et al. Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. J Thorac Cardiovasc Surg 1997;113(3):435-442.
37. Luciani GB, Pessotto R, Mazzucco A. Recurrence of pulmonary hypertension after ventricular septal defect closure and perioperative response to nitric oxide. Int J Cardiol 1998;63(1):85-87.
38. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998;87(1):46-51.
39. Schulze-Neick I, Bultmann M, Werner H, Gammillscheg A, Vogel M, Berger F, et al. Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease. Am J Cardiol 1997;80(3):360-363.
40. Adatia I, Atz AM, Jonas RA, Wessel DL Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 1996;112(5):1403-1405.
41. Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87(2):447-453.
42. Tibballs J. Clinical applications of gaseous nitric oxide. Anaesth Intensive Care 1993;21(6):866-871.
43. Sellden H, Winberg P, Gustafsson LE. Lundell B, Book K, Frostell CG. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant. Anesthesiology 1993;78(3): 577-580.
44. Berner M, Beghetti M, Ricou B, Rouge JC, Pretre R, Friedli B. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993;19(2) 75-77.
45. Heal CA, Spencer SA. Methaemoglobinaemia with high-dose nitric oxide administration. Acta Paediatr 1995;84(11):1318-1319.
46. Nakajima W, Ishida A, Arai H, Takada G. Methaemoglobinaemia after inhalation of nitric oxide in infant with pulmonary hypertension (letter) Lancet 1997;350(9083) 1002-1003.
47. Lavoie A, Hall JB, Olson DM, Wylam ME. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Cm Care Med 1996;153(6 Pt 1):1985-1987.
48. Cuthbertson BH, Dellinger P, Dyar OJ, Evans TE, Higenbottam T, Latimer R. et al UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997;23(12):1212-1218.